Lance Berman, Chief Medical Officer and SVP at Relypsa Inc (RLYP), sold 5,000 shares at $22.00 ($110K) on 2014-09-24, disclosed to the SEC on 2014-09-25.
Scheduled sale ($110k) by Chief Medical Officer and SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RLYP | SELL | 2015-02-25 | $191K | — | Filing → |
| RLYP | SELL | 2014-12-02 | $125K | — | Filing → |
| RLYP | SELL | 2014-11-26 | $750K | — | Filing → |